Domov › Rakovina prsníka › Kalifornia › Mountain View
Klinické štúdie Rakovina prsníka v meste Mountain View, CA
26 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v meste Mountain View a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Prebieha náborFáza 3
- Stanford Women's Cancer Center, Palo Alto · 5 míľ odtiaľ
A Study of PHST001 in Advanced Solid Tumors
Prebieha náborFáza 1
- Stanford University School of Medicine, Palo Alto · 5 míľ odtiaľ
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Prebieha náborFáza 3
- El Camino Hospital, Mountain View
- Palo Alto Medical Foundation, Mountain View
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Prebieha náborFáza 1/2
- Stanford Medicine Cancer Center, Stanford · 5 míľ odtiaľ
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Prebieha náborFáza 3
- El Camino Hospital Cancer Center ( Site 0096), Mountain View
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Prebieha náborFáza 1
- Stanford University Medical Center, Stanford · 5 míľ odtiaľ
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Prebieha náborFáza 1
- Stanford University Medical Center, Stanford · 5 míľ odtiaľ
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Prebieha náborFáza 3
- Stanford Cancer Center, Palo Alto · 5 míľ odtiaľ
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Prebieha náborFáza 3
- Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto · 5 míľ odtiaľ
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Prebieha náborFáza 3
- Stanford Women's Cancer Center, Palo Alto · 5 míľ odtiaľ
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Prebieha náborFáza 1
- Stanford University Hospital, Stanford · 5 míľ odtiaľ
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Prebieha náborFáza 3
- Research Site, Palo Alto · 5 míľ odtiaľ
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Prebieha náborFáza 2
- Stanford Cancer Institute, Palo Alto · 5 míľ odtiaľ
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Prebieha náborFáza 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 míľ odtiaľ
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Prebieha náborFáza 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 míľ odtiaľ
- a 1 ďalších
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
Prebieha náborFáza 2
- Stanford University, Stanford · 5 míľ odtiaľ
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Prebieha náborFáza 2/3
- Local Institution - 0358, Stanford · 5 míľ odtiaľ
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Prebieha náborFáza 3
- Stanford Medicine Cancer Center - Stanford Women's Cancer Center, Palo Alto · 5 míľ odtiaľ
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Prebieha náborFáza 1
- Stanford University Medical Center, Palo Alto · 5 míľ odtiaľ
Magnetic Resonance Imaging of Breast Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Stanford University School of Medicine, Stanford · 5 míľ odtiaľ
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Prebieha náborObservačná štúdia
- Stanford University School of Medicine, Stanford · 5 míľ odtiaľ
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Prebieha náborFáza 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 míľ odtiaľ
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 míľ odtiaľ
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Prebieha náborFáza 1
- Stanford Cancer Institute, Stanford · 5 míľ odtiaľ
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Prebieha nábor
- Stanford University, Stanford · 5 míľ odtiaľ
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Prebieha náborObservačná štúdia
- Stanford Cancer Institute, Palo Alto · 5 míľ odtiaľ
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Stanford · 5 míľ odtiaľ
Štúdie Rakovina prsníka v iných mestách
- New York City, NY136 štúdií
- Houston, TX126 štúdií
- Boston, MA112 štúdií
- Nashville, TN81 štúdií
- Los Angeles, CA73 štúdií
- Edison, NJ68 štúdií
- St. Louis, MO64 štúdií
- Queens, NY64 štúdií
- Durham, NC64 štúdií
- Chicago, IL59 štúdií
- Philadelphia, PA56 štúdií
- Dallas, TX55 štúdií
Iné štúdie v Mountain View
- Rakovina (všetky typy)40 štúdií
- Metastatická rakovina25 štúdií
- Nemalobunkový karcinóm pľúc21 štúdií
- Akútna myeloidná leukémia19 štúdií
- Rakovina vaječníkov19 štúdií
- Porucha autistického spektra17 štúdií
- Rakovina pľúc17 štúdií
- Rakovina prostaty15 štúdií
- Srdcové zlyhanie15 štúdií
- Autizmus13 štúdií
- Akútna lymfoblastová leukémia13 štúdií
- Kolorektálny karcinóm13 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.